Results 231 to 240 of about 1,468,461 (396)

Toxicities associated with lymphoma-targeting bispecific antibodies-a review. [PDF]

Front Med (Lausanne)
Doig C, Yannakou CK.
europepmc   +1 more source

Targeting properties of an anti-CD16/anti-CD30 bispecific antibody in an in vivo system

, 2001
Christoph Renner, Ingo Stehle, Fook Thean Lee, Cathrine Hall, Bruno Catimel, Edouard C. Nice, Angela Mountain, Angela Rigopoulos, Martin W. Brechbiel, M. Pfreundschuh, Andrew M. Scott   +10 more
openalex   +1 more source

Selective Targeting and Potent Control of Tumor Growth Using an EphA2/CD3-Bispecific Single-Chain Antibody Construct [PDF]

, 2007
Scott A. Hammond, Ralf Lutterbuese, Shannon Roff, Petra Lutterbuese, Bernd Schlereth, Elizabeth Bruckheimer, Michael S. Kinch, Steve Coats, Patrick A. Baeuerle, Peter Kufer, Peter A. Kiener   +10 more
openalex   +1 more source

Allogeneic transplantation after failure of chimeric antigen receptor‐T cells and exposure to bispecific antibodies: Feasibility, safety and survival outcomes

British Journal of Haematology, EarlyView.
Summary Clinical outcome after chimeric antigen receptor (CAR)‐T‐cell failure in large B‐cell lymphoma (LBCL) is dismal. Allogeneic stem cell transplantation (alloSCT) represents a potentially curative salvage for relapsed/refractory LBCL, although concerns remain regarding its feasibility and safety in patients exposed to CAR‐T and bispecific ...
Angelica Barone, Chiara De Philippis, Federico Stella, Anna Dodero, Barbara Sarina, Martina Pennisi, Armando Santoro, Carmelo Carlo‐Stella, Anna Guidetti, Stefania Bramanti, Paolo Corradini   +10 more
wiley   +1 more source

Recent Advances in Antibody Therapy for Alzheimer's Disease: Focus on Bispecific Antibodies. [PDF]

Int J Mol Sci
Yang HM.
europepmc   +1 more source

T cells expressing CD19-specific Engager Molecules for the Immunotherapy of CD19-positive Malignancies [PDF]

, 2017
Arber, Caroline, Bonifant, Challice Lee, Cooper, Laurence J. N., Gerken, Claudia, Gottschalk, Stephen, Iwahori, Kota, Kakarla, Sunitha, Rodriguez-Cruz, Tania, Song, Xiao-Tong, Szöőr, Árpád, Torres, David, Velasquez, Mireya Paulina   +11 more
core   +1 more source

Improved Pharmacokinetics of Recombinant Bispecific Antibody Molecules by Fusion to Human Serum Albumin [PDF]

, 2007
Dafne Müller, Anette Karle, Bettina Meißburger, Ines Höfig, Roland Stork, Roland E. Kontermann   +5 more
openalex   +1 more source

CD123‐targeting immunotherapeutic approaches in acute myeloid leukaemia

British Journal of Haematology, EarlyView.
Summary Treatment of relapsed or refractory acute myeloid leukaemia (AML) has remained a significant challenge, with limited available targeted immunotherapies. CD123, or the interleukin‐3 (IL‐3) receptor, has long been known as a potential target expressed on AML blasts, and a range of different approaches to targeting CD123 have been trialled with ...
Alexandra Dreyzin, Noa G. Holtzman, Challice L. Bonifant   +2 more
wiley   +1 more source

Bispecific anti-CD20/22 antibodies inhibit B-cell lymphoma proliferation by a unique mechanism of action [PDF]

, 2007
Zhengxing Qu, David M. Goldenberg, Thomas M. Cardillo, Victoria Shi, Hans J. Hansen, Chien‐Hsing Chang   +5 more
openalex   +1 more source

Bispecific Antibodies in Solid Tumors: Advances and Challenges. [PDF]

Int J Mol Sci
Shan KS, Musleh Ud Din S, Dalal S, Gonzalez T, Dalal M, Ferraro P, Hussein A, Vulfovich M.   +7 more
europepmc   +1 more source